The global Blood Pressure Monitoring Devices market gathered revenue around USD 1.0 Billion in 2020 and market is set to grow USD 3.20 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 8.20% during the prediction period 2021 to 2027.
Blood circulating against the walls of blood vessels generates blood pressure (BP) and is measured in millimeters of mercury (mmHg). Factors influencing blood pressure include cardiac output, systemic vascular resistance & arterial stiffness, emotional state, activity, and relative health/disease states. Blood pressure disorders include hypertension, cardiac arrest, stroke, and sometimes renal failure.
Devices measuring blood pressure include sphygmomanometers, ambulatory blood pressure monitors, automatic blood pressure monitors, and blood pressure transducers Sphygmomanometers are the widely used blood pressure monitors due to easy availability, ease of use, and lower cost.In terms of device, the global blood pressure monitoring devices market has been classified into sphygmomanometers, automatic blood pressure monitors, ambulatory blood pressure monitors, and blood pressure transducers. The sphygmomanometers segment has been split into mercury, aneroid, and digital sphygmomanometers. The sphygmomanometers segment held significant share of the global blood pressure monitoring devices market in 2020.
This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Blood Pressure Monitoring Devices market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Blood Pressure Monitoring Devices market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.
COVID-19 Impact Assessment on Market Landscape
The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.
Blood Pressure Monitoring Devices market report empower readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.
Report Highlights | Details |
Market Size | US$ 3.20 Billion by 2027 |
Growth Rate | CAGR of 8.20% From 2021 to 2027 |
Base Year | 2020 |
Historic Data | 2017 to 2020 |
Forecast Period | 2021 to 2027 |
Segments Covered | Device,End-user,Regional |
Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
Companies Mentioned | Omron Healthcare, Inc., Celularity, Inc., Koninklijke Philips N.V, GE Healthcare (General Electric Company), Welch Allyn, Inc. (Hill-Rom Holdings, Inc.), Schiller AG, American Diagnostic Corporation, SPENGLER, Spacelabs Healthcare, Withings SA, SunTech Medical, Inc. (Halma plc), and A&D Medical. |
Competitive Rivalry
Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
Some of the prominent players in the Blood Pressure Monitoring Devices Market include: Omron Healthcare, Inc., Celularity, Inc., Koninklijke Philips N.V, GE Healthcare (General Electric Company), Welch Allyn, Inc. (Hill-Rom Holdings, Inc.), Schiller AG, American Diagnostic Corporation, SPENGLER, Spacelabs Healthcare, Withings SA, SunTech Medical, Inc. (Halma plc), and A&D Medical.
Unravelling the Critical Segments
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:
Blood Pressure Monitoring Devices Market – Segmentation
Blood Pressure Monitoring Devices Market, by Device
Blood Pressure Monitoring Devices Market, by End-user
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Highlights of the Report:
Research Methodology
In the study, a unique research methodology is utilized to conduct extensive research on the growth of the Blood Pressure Monitoring Devices market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the Blood Pressure Monitoring Devices market study are as follows - statistics from government organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, all of whom have contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the market, and makes the projections on the growth prospects of the Blood Pressure Monitoring Devices markets more accurate and reliable.
Secondary Research
It involves company databases such as Hoover's: This assists us recognize financial information, structure of the market participants and industry competitive landscape.
The secondary research sources referred in the process are as follows:
Primary Research
Primary research includes face-to face interviews, online surveys, and telephonic interviews.
Industry participants involved in this research study include:
Key Points Covered in Blood Pressure Monitoring Devices market Study:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Blood Pressure Monitoring Devices Market, By Device
7.1. Blood Pressure Monitoring Devices Market, by Device, 2021-2027
7.1.1. Sphygmomanometers
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Mercury Sphygmomanometers
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Aneroid Sphygmomanometers
7.1.3.1. Market Revenue and Forecast (2016-2027)
7.1.4. Digital Sphygmomanometers
7.1.4.1. Market Revenue and Forecast (2016-2027)
7.1.5. Digital Sphygmomanometers
7.1.5.1. Market Revenue and Forecast (2016-2027)
7.1.6. Ambulatory Blood Pressure Monitors
7.1.6.1. Market Revenue and Forecast (2016-2027)
7.1.7. Blood Pressure Transducers
7.1.7.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global Blood Pressure Monitoring Devices Market, By End-user
8.1. Blood Pressure Monitoring Devices Market, by End-user, 2021-2027
8.1.1. Hospitals & Clinics
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Ambulatory Surgical Centers
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Homecare Settings
8.1.3.1. Market Revenue and Forecast (2016-2027)
8.1.4. Others
8.1.4.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Blood Pressure Monitoring Devices Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, by Device (2016-2027)
9.1.2. Market Revenue and Forecast, by End-user (2016-2027)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Device (2016-2027)
9.1.3.2. Market Revenue and Forecast, by End-user (2016-2027)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Device (2016-2027)
9.1.4.2. Market Revenue and Forecast, by End-user (2016-2027)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Device (2016-2027)
9.2.2. Market Revenue and Forecast, by End-user (2016-2027)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Device (2016-2027)
9.2.3.2. Market Revenue and Forecast, by End-user (2016-2027)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Device (2016-2027)
9.2.4.2. Market Revenue and Forecast, by End-user (2016-2027)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Device (2016-2027)
9.2.5.2. Market Revenue and Forecast, by End-user (2016-2027)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Device (2016-2027)
9.2.6.2. Market Revenue and Forecast, by End-user (2016-2027)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Device (2016-2027)
9.3.2. Market Revenue and Forecast, by End-user (2016-2027)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Device (2016-2027)
9.3.3.2. Market Revenue and Forecast, by End-user (2016-2027)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Device (2016-2027)
9.3.4.2. Market Revenue and Forecast, by End-user (2016-2027)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Device (2016-2027)
9.3.5.2. Market Revenue and Forecast, by End-user (2016-2027)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Device (2016-2027)
9.3.6.2. Market Revenue and Forecast, by End-user (2016-2027)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Device (2016-2027)
9.4.2. Market Revenue and Forecast, by End-user (2016-2027)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Device (2016-2027)
9.4.3.2. Market Revenue and Forecast, by End-user (2016-2027)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Device (2016-2027)
9.4.4.2. Market Revenue and Forecast, by End-user (2016-2027)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Device (2016-2027)
9.4.5.2. Market Revenue and Forecast, by End-user (2016-2027)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Device (2016-2027)
9.4.6.2. Market Revenue and Forecast, by End-user (2016-2027)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Device (2016-2027)
9.5.2. Market Revenue and Forecast, by End-user (2016-2027)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Device (2016-2027)
9.5.3.2. Market Revenue and Forecast, by End-user (2016-2027)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Device (2016-2027)
9.5.4.2. Market Revenue and Forecast, by End-user (2016-2027)
Chapter 10. Company Profiles
10.1. Omron Healthcare, Inc.
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Celularity, Inc.
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Koninklijke Philips N.V
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. GE Healthcare
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Welch Allyn, Inc.
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Schiller AG
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. American Diagnostic Corporation
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. SPENGLER
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Spacelabs Healthcare
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. Withings SA
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms